GSK vs TVTX · P/E 13, $103.31B cap vs rev $296.8M
GlaxoSmithKline PLC ADR (GSK) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported TVTX revenue for 2026-06-30 was $296.8M. Net income was -$71.9M. TVTX currently screens at market cap $1.33B.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the GSK and TVTX stock pages for the full models.
Not investment advice.